Major contract research organizations by revenue 2025| ��ƽ��

Leading global contract research organizations (CROs) 2025, based on revenue (in million U.S. dollars)

Characteristic	Revenue in million U.S. dollars
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Sources

Release date

2026

More information

Region

Worldwide

Survey time period

2025

Supplementary notes

* Only Laboratory Products & Biopharma Services segment. No separate information about pure clinical research-related revenues.

** Estimated.

Citation formats

In 2025, the first-ranked company, Thermo Fisher Scientific, which acquired Pharmaceutical Product Development (PPD) in 2021, generated about ** billion U.S. dollars in revenue through its clinical research business in 2025. The other leading contract research organizations worldwide included IQVIA and Laboratory Corporation of America Holdings.

Contract research organizations

Contract research organizations (CROs) are companies that are contracted by larger pharmaceutical companies to manage select aspects of clinical trials. Today, CROs are essential for pharmaceutical research and development. Pharmaceutical companies are spending more money than ever on research and development, and there is no indication that spending will decrease in the future. Evidence suggests that CROs will become even more valuable. The clinical CRO market is expected to increase to over *** billion U.S. dollars by the beginning of the next decade.

Pharmaceutical research and development

Globally, Roche and Johnson & Johnson will be the top pharmaceutical companies based on their projected research and development spending. There are regional differences in research and development among pharmaceutical companies. Of all pharmaceutical companies globally, those based in the U.S. develop the highest number of new chemical or biological entities.